Back to the list
Congress: ECR25
Poster Number: C-27959
Type: Poster: EPOS Radiologist (educational)
Authorblock: M. C. V. Lauar, A. S. Malta, C. Colombo, J. Hiraoka Catani, C. D. Pinheiro, E. E. Françolin, A. L. P. Costa, N. Lima, R. Linhares; São Paulo/BR
Disclosures:
Marcela Caetano Vilela Lauar: Nothing to disclose
Alessandra Silva Malta: Nothing to disclose
Caroline Colombo: Nothing to disclose
Juliana Hiraoka Catani: Nothing to disclose
Caio Dinelli Pinheiro: Nothing to disclose
Erica Elisangela Françolin: Nothing to disclose
Aline Lemgruber Prado Costa: Nothing to disclose
Natalia Lima: Nothing to disclose
Roberta Linhares: Nothing to disclose
Keywords: Breast, Mammography, MR, Ultrasound, Biopsy, Education, Cancer, Education and training
References

1- Epidemiologic Evidence of Slow Growing, Nonprogressive or Regressive Breast Cancer: A Systematic Review. Segnan N, Minozzi S, Armaroli P, et al. International Journal of Cancer. 2016;139(3):554-73. doi:10.1002/ijc.30105.

2- A Breast Cancer Gene Signature for Indolent Disease. Delahaye LJMJ, Drukker CA, Dreezen C, et al. Breast Cancer Research and Treatment. 2017;164(2):461-466. doi:10.1007/s10549-017-4262-0.

3- Detection and Significance of Small and Low Proliferation Breast Cancer. Hofvind S, Knutsvik G, Holen ÅS, Tsuruda KM, Akslen LA. Journal of Medical Screening. 2022;29(1):32-37. doi:10.1177/09691413211023970.

4- Clinicopathological Characteristics and Survival Results of Patients With Ultralow Risk Breast Cancer.  Baena-Cañada JM, Gámez-Casado S, Rodríguez-Pérez L, et al. Medicina Clinica. 2022;159(8):351-358. doi:10.1016/j.medcli.2021.11.008

5- Detection and Significance of Small and Low Proliferation Breast Cancer.  Hofvind S, Knutsvik G, Holen ÅS, Tsuruda KM, Akslen LA. Journal of Medical Screening. 2022;29(1):32-37. doi:10.1177/09691413211023970.

6- Modeling of the Growth Kinetics of Occult Breast Tumors: Role in Interpretation of Studies of Prevention and Menopausal Hormone Therapy. Santen RJ, Yue W, Heitjan DF. Cancer Epidemiology, Biomarkers & Prevention. 2012;21(7):1038-48. doi:10.1158/1055-9965.EPI-12-0043.

7- Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study. Van Steenhoven JEC et al. Genes (Basel). 2018 May 17;9(5):261. doi: 10.3390/genes9050261.

8- Ductal carcinoma in situ: the whole truth. Parikh U, Chhor CM, Mercado CL. AJR Am J Roentgenol. 2018 Feb;210(2):246-255. doi: 10.2214/AJR.17.18778.

9- The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project. Maxwell AJ et al: Breast. 2016 Jun;27:109-115. doi: 10.1016/j.breast.2016.03.004.

10- Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast. Poirier É, Desbiens C, Poirier B, Boudreau D, Jacob S, Lemieux J, Doyle C, Diorio C, Hogue JC, Provencher L. J Surg Oncol. 2018 May;117(6):1137-1143. doi: 10.1002/jso.24944. 

11- The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study. Zhou, X., Zheng, Z., Li, Y., Zhao, W., Lin, Y., Zhang, J., & Sun, Q. (2021). BMC Cancer. 2021 21(1), 536.

12- Best cases from the AFIP: intracystic papillary carcinoma of the breast. Rodríguez MC, Secades AL, Angulo JM. Radiographics. 2010;30 (7): 2021-7. doi:10.1148/rg.307105003
GALLERY